{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T01:29:04Z","timestamp":1774747744467,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.7759\/cureus.83479","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:32:58Z","timestamp":1746419578000},"source":"Crossref","is-referenced-by-count":2,"title":["A Tragic Tale of Mucormycosis and COVID-19: An Observational Study to Identify Predisposing Risk Factors and Outcomes in a Tertiary Care Centre in Central India"],"prefix":"10.7759","author":[{"given":"Vandana","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Kubre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tripti","family":"Vatsalya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Ahirwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. India. (2023). Accessed: April 29, 2025: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"ref2","article-title":"Textbook of Medical Mycology. 4th ed.","author":"Chander J","year":"2018","unstructured":"Chander J. Textbook of Medical Mycology. 4th ed.. Jaypee Brothers' Medical Publishers, 2018."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-013-0152-z","article-title":"Epidemiology of mucormycosis in India","volume":"7","author":"Chakrabarti A","year":"2013","unstructured":"Chakrabarti A, Dhaliwal M. Epidemiology of mucormycosis in India. Curr Fungal Infect Rep. 2013, 7:287-292. 10.1007\/s12281-013-0152-z","journal-title":"Curr Fungal Infect Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-653. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01145.x","article-title":"Mucormycosis-associated fungal infections in patients with haematologic malignancies","volume":"63","author":"Kara IO","year":"2009","unstructured":"Kara IO, Tasova Y, Uguz A, Sahin B. Mucormycosis-associated fungal infections in patients with haematologic malignancies. Int J Clin Pract. 2009, 63:134-139. 10.1111\/j.1742-1241.2006.01145.x","journal-title":"Int J Clin Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world","volume":"186","author":"Muthu V","year":"2021","unstructured":"Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia. 2021, 186:739-754. 10.1007\/s11046-021-00584-8","journal-title":"Mycopathologia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycres.2007.03.004","article-title":"A higher-level phylogenetic classification of the Fungi","volume":"111","author":"Hibbett DS","year":"2007","unstructured":"Hibbett DS, Binder M, Bischoff JF, et al.. A higher-level phylogenetic classification of the Fungi. Mycol Res. 2007, 111:509-547. 10.1016\/j.mycres.2007.03.004","journal-title":"Mycol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos G","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012, 54:S23-S34. 10.1093\/cid\/cir866","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.05.005","article-title":"COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review","volume":"121","author":"Balushi AA","year":"2022","unstructured":"Balushi AA, Ajmi AA, Sinani QA, et al.. COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review. Int J Infect Dis. 2022, 121:203-210. 10.1016\/j.ijid.2022.05.005","journal-title":"Int J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim AS","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012, 54:S16-S22. 10.1093\/cid\/cir865","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash H","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021, 9:523. 10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"ref12","article-title":"Diabetes Atlas. Ninth Edition","author":"Williams R","year":"2019","unstructured":"Williams R, Colagiuri S, Almutairi R, et al.. Diabetes Atlas. Ninth Edition. International Diabetes Federation, 2019."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-Associated mucormycosis, India","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, et al.. Multicenter epidemiologic study of coronavirus disease-Associated mucormycosis, India. Emerg Infect Dis. 2021, 27:2349-2359. 10.3201\/eid2709.210934","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.25259\/NMJI-35-3-132","article-title":"Covid-19-associated rhino-orbito-cerebral mucormycosis (CAROM) in Delhi: demographics and risk factors in a single-centre consecutive cohort of 200 inpatients","volume":"35","author":"Singh A","year":"2022","unstructured":"Singh A, Sikka K, Goel G, et al.. Covid-19-associated rhino-orbito-cerebral mucormycosis (CAROM) in Delhi: demographics and risk factors in a single-centre consecutive cohort of 200 inpatients. Natl Med J India. 2022, 35:132-137. 10.25259\/NMJI-35-3-132","journal-title":"Natl Med J India"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/med-2021-0250","article-title":"Judicious use of low-dosage corticosteroids for non-severe COVID-19: a case report","volume":"16","author":"Zhang J","year":"2021","unstructured":"Zhang J, Tian Z, Feng L, et al.. Judicious use of low-dosage corticosteroids for non-severe COVID-19: a case report. Open Med. 2021, 16:440-445. 10.1515\/med-2021-0250","journal-title":"Open Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly JP","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al.. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020, 71:1367-1376. 10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/IJCFM.IJCFM_10_19","article-title":"Prevalence of polypharmacy: comparing the status of Indian states","volume":"5","author":"Sharma P","year":"2019","unstructured":"Sharma P, Gupta N, Chauhan H. Prevalence of polypharmacy: comparing the status of Indian states. Indian J Community Fam Med. 2019, 5:4-9. 10.4103\/IJCFM.IJCFM_10_19","journal-title":"Indian J Community Fam Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal R","year":"2021","unstructured":"Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, Kumar A. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021, 64:1452-1459. 10.1111\/myc.13338","journal-title":"Mycoses"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.52403\/ijhsr.20210817","article-title":"Review of published case reports of COVID-19 associated mucormycosis with search of therapeutic potential in ayurveda and homeopathy","volume":"11","author":"Javed D","year":"2021","unstructured":"Javed D, Dixit AK, Vats H, Anwar S, Giri N. Review of published case reports of COVID-19 associated mucormycosis with search of therapeutic potential in ayurveda and homeopathy. Int J Health Sci Res. 2021, 11:114-126. 10.52403\/ijhsr.20210817","journal-title":"Int J Health Sci Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert B","year":"2012","unstructured":"Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O. Healthcare-associated mucormycosis. Clin Infect Dis. 2012, 54:S44-S54. 10.1093\/cid\/cir867","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2019.07.001","article-title":"Anesthetic management of rhinoorbitocerebral mucormycosis; focus on challenges","volume":"29","author":"Karaaslan E","year":"2019","unstructured":"Karaaslan E. Anesthetic management of rhinoorbitocerebral mucormycosis; focus on challenges. J Mycol Med. 2019, 29:219-222. 10.1016\/j.mycmed.2019.07.001","journal-title":"J Mycol Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/joacp.joacp_169_22","article-title":"Perioperative anesthesia challenges and outcomes of patients with rhino-orbito-cerebral mucormycosis during the second wave of COVID-19 pandemic: an observational study","volume":"39","author":"Kumari K","year":"2023","unstructured":"Kumari K, Rathod D, Meshram T, et al.. Perioperative anesthesia challenges and outcomes of patients with rhino-orbito-cerebral mucormycosis during the second wave of COVID-19 pandemic: an observational study. J Anaesthesiol Clin Pharmacol. 2023, 39:615-621. 10.4103\/joacp.joacp_169_22","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/ija.ija_470_21","article-title":"Anaesthetic considerations for post-COVID-19 mucormycosis surgery- A case report and review of literature","volume":"65","author":"Gupta KK","year":"2021","unstructured":"Gupta KK, Singh A, Kalia A, Kandhola R. Anaesthetic considerations for post-COVID-19 mucormycosis surgery- A case report and review of literature. Indian J Anaesth. 2021, 65:545-547. 10.4103\/ija.ija_470_21","journal-title":"Indian J Anaesth"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-4-46","article-title":"Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans","volume":"4","author":"Barodka VM","year":"2006","unstructured":"Barodka VM, Acheampong E, Powell G, et al.. Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. J Transl Med. 2006, 4:46. 10.1186\/1479-5876-4-46","journal-title":"J Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101702-a-tragic-tale-of-mucormycosis-and-covid-19-an-observational-study-to-identify-predisposing-risk-factors-and-outcomes-in-a-tertiary-care-centre-in-central-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:32:59Z","timestamp":1746419579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101702-a-tragic-tale-of-mucormycosis-and-covid-19-an-observational-study-to-identify-predisposing-risk-factors-and-outcomes-in-a-tertiary-care-centre-in-central-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,4]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.83479","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,4]]}}}